Centene (NYSE:CNC) & Leap Technology (OTCMKTS:LPTC) Financial Contrast

Leap Technology (OTCMKTS:LPTCGet Free Report) and Centene (NYSE:CNCGet Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, valuation, dividends and analyst recommendations.

Valuation & Earnings

This table compares Leap Technology and Centene”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Leap Technology N/A N/A N/A N/A N/A
Centene $169.28 billion 0.16 $3.31 billion $6.71 7.99

Centene has higher revenue and earnings than Leap Technology.

Profitability

This table compares Leap Technology and Centene’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Leap Technology N/A N/A N/A
Centene 2.04% 14.56% 4.75%

Insider and Institutional Ownership

93.6% of Centene shares are held by institutional investors. 1.1% of Leap Technology shares are held by insiders. Comparatively, 0.4% of Centene shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Leap Technology and Centene, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Leap Technology 0 0 0 0 0.00
Centene 0 7 9 0 2.56

Centene has a consensus target price of $77.71, indicating a potential upside of 45.04%. Given Centene’s stronger consensus rating and higher probable upside, analysts clearly believe Centene is more favorable than Leap Technology.

Summary

Centene beats Leap Technology on 8 of the 9 factors compared between the two stocks.

About Leap Technology

(Get Free Report)

Le@P Technology, Inc. does not have significant operations. The company plans to pursue acquisition, joint venture, and investment opportunities primarily in the areas of health care technology, and products and services, as well as life sciences. Previously, it was involved in leasing a real property. Le@P Technology, Inc. was founded in 1997 and is based in Fort Lauderdale, Florida.

About Centene

(Get Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.

Receive News & Ratings for Leap Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leap Technology and related companies with MarketBeat.com's FREE daily email newsletter.